ACA Premiums Could Increase as Much as 20%
The Society of Actuaries has estimated that premiums for the Affordable Care Act’s plans could increase by 10% to 20%. Bloomberg BNA reported that premiums could increase more, and additional insurers could exit some markets, if the cost-sharing reduction subsidies are not funded. State deadlines for filing rates vary, but there is a federal deadline of June 21 for some filings. Insurers who file rates will have until the fall to decide whether or not they will ultimately participate in the exchanges for 2018.
Cherokee Nation Files Suit Against Drug Distributors
A lawsuit filed in tribal court accuses drug distributors and pharmacies of the devastation caused by addictive pain pills that flooded into Oklahoma. According to The Washington Post, the suit says the 6 defendants named turned a “blind eye” to the situation of pain pills being diverted to the black market. The defendants named were McKesson, Cardinal Health, AmerisourceBergen, CVS, Walgreens, and Walmart. The attorney general for the Cherokees said these companies should have known they were sending too many pills to realistically only be used for “legitimate medical purposes.”
FDA Warns Against Codeine and Tramadol for Children
After identifying more than 70 cases of serious breathing problems, the FDA has expanded safety warnings for codeine and tramadol products to treat pain or relieve cough in children. Included in the cases were 27 deaths. Most of the side effects linked to the medications occurred in children younger than age 12, and sometimes 1 dose was all that was needed, reported The Wall Street Journal. The FDA is now warning neither drug should be used in children younger than 12 and that tramadol shouldn’t be used in patients younger than 18 after tonsil- or adenoid-removal surgery. Breast-feeding mothers should also not take these medications.
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
What We’re Reading: Affordable Home Care; Mycoplasma Infections Rise; Opioid Crisis Settlement
December 4th 2023Families struggle to find affordable, reliable home health aides; reports of increased pediatric pneumonia cases; legal battle ensues over Purdue Pharma’s bankruptcy settlement.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
What We’re Reading: Affordable Home Care; Mycoplasma Infections Rise; Opioid Crisis Settlement
December 4th 2023Families struggle to find affordable, reliable home health aides; reports of increased pediatric pneumonia cases; legal battle ensues over Purdue Pharma’s bankruptcy settlement.
Read More
2 Clarke Drive
Cranbury, NJ 08512